Archives of general psychiatry

publication venue for

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.. 69. 2012
A multisite study of the clinical diagnosis of different autism spectrum disorders.. 69. 2011
Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia.. 69. 2011
Collaborative depression care management and disparities in depression treatment and outcomes.. 68. 2011
Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability.. 68. 2011
High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication.. 67. 2010
Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder.. 66. 2009
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.. 66. 2009
A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).. 66. 2009
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking.. 66. 2009
Higher burden of depression among older women: the effect of onset, persistence, and mortality over time.. 65. 2008
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.. 64. 2007
Autism from 2 to 9 years of age.. 63. 2006
Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.. 63. 2006
A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care.. 62. 2005
Predictors of treatment acceptance and completion in anorexia nervosa: implications for future study designs.. 62. 2005
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.. 62. 2005
Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.. 61. 2004
Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset.. 61. 2004
Prospective investigation of stress inoculation in young monkeys.. 61. 2004
Brain metabolic alterations in medication-free patients with bipolar disorder.. 61. 2004
Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia.. 60. 2003
Using chronic pain to predict depressive morbidity in the general population.. 60. 2003
Hypnotic suggestion and the modulation of Stroop interference.. 59. 2002
Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia.. 59. 2002
Predictors of early recovery from major depression among persons admitted to community-based clinics: an observational study.. 59. 2002
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.. 59. 2002
Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression.. 59. 2002
Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder.. 59. 2002
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.. 59. 2002
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.. 59. 2002
Early life stress and inherited variation in monkey hippocampal volumes.. 58. 2001
Amygdala response to fearful faces in anxious and depressed children.. 58. 2001
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.. 58. 2001
Use of mental health and substance abuse treatment services among adults with HIV in the United States.. 58. 2001
Reviewers list: reviewers for 2000. 57. 2000
24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression.. 57. 2000
Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings.. 57. 2000
Executive dysfunction and long-term outcomes of geriatric depression.. 57. 2000
Clinical determinants of suicidal ideation and behavior in geriatric depression.. 56. 1999
Prefrontal dysfunction and treatment response in geriatric depression.. 56. 1999
Treatment of depressive symptoms in human immunodeficiency virus-positive patients.. 55. 1998
Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task.. 55. 1998
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.. 53. 1996
Recovery in geriatric depression.. 53. 1996
More reliable outcome measures can reduce sample size requirements.. 52. 1995
Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life.. 52. 1995
Effect of innervation on heart rate response to mental stress.. 50. 1993
Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients.. 49. 1992
The effect of access to lethal methods of injury on suicide rates.. 49. 1992
Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus.. 49. 1992
Trait-state artifacts and the diagnosis of personality disorders.. 48. 1991
Poverty and psychiatric status. Longitudinal evidence from the New Haven Epidemiologic Catchment Area study.. 48. 1991
Effectiveness of psychoeducational interventions in reducing emotional distress after human immunodeficiency virus antibody testing.. 48. 1991
Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims.. 47. 1990
Factors associated with 1-year outcome of major depression in the community.. 47. 1990
Normalization of blunted lymphocyte beta-adrenergic responsivity in melancholic inpatients by a course of electroconvulsive therapy.. 47. 1990
Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study.. 46. 1989
Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.. 46. 1989
A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor.. 46. 1989
Asymmetries in hemispheric control of attention in schizophrenia.. 45. 1988
Comorbidity of borderline personality disorder.. 45. 1988
Blunted beta-adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression. Isoproterenol dose-response studies.. 45. 1988
Imipramine treatment for chronic depression.. 45. 1988
Inpatient family intervention: a randomized clinical trial. II. Results at hospital discharge.. 45. 1988
Tardive dyskinesia and steady-state serum levels of thiothixene.. 44. 1987
A multidimensional scaling of the DSM-III personality disorders.. 44. 1987
Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims.. 43. 1986
Neurochemistry of dopamine in Huntington's dementia and normal aging.. 43. 1986
Maprotiline treatment in depression. A perspective on seizures.. 43. 1986
A controlled evaluation of inpatient family intervention. I. Preliminary results of the six-month follow-up.. 42. 1985
Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus.. 41. 1984
Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus.. 41. 1984
Diagnostic efficiency and DSM-III.. 41. 1984
Structured interviews and borderline personality disorder.. 41. 1984
Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxification.. 40. 1983
Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.. 40. 1983
Plasma immunoreactive beta-endorphin levels in depression. Effect of electroconvulsive therapy.. 40. 1983
Diagnosing borderline conditions in an outpatient setting.. 40. 1983
Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history.. 39. 1982
The effect of psychobiological research on treatment outcome. A controlled study.. 38. 1981
A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.. 38. 1981
beta-Endorphin and schizophrenia.. 37. 1980
Assault, suicide, and mental illness.. 37. 1980
Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.. 35. 1978
Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.. 35. 1978
Benzodiazepines in depressive disorders.. 35. 1978
Platelet methylene reductase activity in schizophrenia.. 34. 1977
Relationship of lithium chloride dose to treatment response in acute mania.. 33. 1976
Schizophrenia and stimulus intensity control.. 32. 1975
Psychotherapy in hospitalized research patients.. 32. 1975
Tryptolines. Formation from tryptamines and 5-MTHF by human platelets.. 31. 1974
Ineffective military personnel. II. An ethical dilemma for psychiatry.. 30. 1974
Recovery from delusions. Three phases documented by patient's interpretation of research procedures.. 30. 1974
Wilhelm Reich: self-destined victim and social casualty. A study of his trial and appeal.. 27. 1972
Alternative interpretation of Swedish twin study findings on personality and major depression.. 64. 2007
Psychoanalytic contributions to psychiatry.. 59. 2002
Looking back: the history of psychiatry in the 21st century.. 56. 1999
Treating imagined ugliness.. 56. 1999
Protecting vulnerable research subjects without unduly constraining neuropsychiatric research.. 56. 1999
Distinguishing apathy syndromes from vascular depression.. 55. 1998
Depression after transient ischemic attack: a clinically distinct subtype of vascular depression?. 55. 1998
Psychotherapy and managed care.. 55. 1998
The role of psychotherapy: psychiatry's resistance to managed care.. 55. 1998
Half a loaf: is compromise the best policy?. 55. 1998
Reciprocal lateralization of frontal lobe functions.. 52. 1995
Postdexamethasone cortisol levels and subgroups of affective illness.. 42. 1985
Induction of mania.. 40. 1983
The irony of autism. 1998
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. 2002
A thanks to the ARCHIVES community: our farewell editorial.. 58. 2001
A 'second life' agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. 1997
'Vascular depression' hypothesis. 1997
The current state of psychiatry in the treatment of violent patients. 1992
Psychotherapy of depression. Implications for reform of the health care system. 1996

VIVO Weill Cornell Medical College

Archives of general psychiatry Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)